Purchase Order 75N93021P01498
- Not listed
- This is a firm fixed price purchase order for $34,902.00 awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health, to Olink Proteomics AB, a foreign-owned for-profit entity based in Sweden. The contract is for the delivery of Olink Proteomics' proprietary Inflammation reagent kits and Dynamic Array chips, which support multiplex protein biomarker analysis. This purchase order was awarded under simplified acquisition procedures...
- The Department of Health and Human Services, National Institutes of Health, National Human Genome Research Institute awarded a firm fixed price purchase order contract to Olink Proteomics AB, a foreign-owned for-profit organization, to evaluate multiple proteins in plasma samples. The $247,996.10 contract has a performance period ending on May 13, 2023. No set-aside designation was used for this award. Olink Proteomics AB specializes in proprietary multiplex protein biomarker analysis...
- This firm fixed price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Olink Proteomics AB, a foreign-owned for-profit manufacturer based in Sweden. The $85,000.00 contract is for the delivery of 10 inflammation reagent kits and associated array chips to support NIAID's biomedical research efforts, particularly in the areas of cancer, cardiovascular disease, infectious...
- The Department of Health and Human Services' National Institutes of Health awarded a firm-fixed-price purchase order to Olink Proteomics AB, a foreign-owned for-profit organization, for $237,000 to provide Olink's proprietary proteomics reagent kits and array chips to support COVID-19 research. The award does not have a set-aside designation. Olink has previously provided similar proteomics services and reagents to federal agencies like the NIH, FDA, and VA to support research across disease...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm-fixed-price purchase order to Olink Proteomics Inc., a foreign-owned for-profit organization, in the amount of $113,936.00. The award is for the delivery of Olink's integrated fluidic circuits and reagent kits to support the Viral Pathogenesis and Evolution Section's research into the development of universal influenza and SARS-CoV-2 vaccines. The...
- The National Institutes of Health's National Human Genome Research Institute awarded a $697,695 firm fixed price purchase order to Olink Proteomics AB of Uppsala, Sweden. The one-year contract calls for Olink to measure the proteomic profiles of 1,000 plasma samples across 3,072 proteins using its proprietary Olink Explore 3072 technology. Performance will take place at Olink's facilities in Uppsala and Boston. There was no set-aside designation, as the sole-source award was made directly to...
- This firm fixed-price purchase order, awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to Olink Proteomics AB, a foreign-owned for-profit manufacturer based in Sweden, is for $48,240.00 to provide inflammatory and immune response protein analysis services. The contract does not have a set-aside designation. Olink Proteomics AB has provided similar proteomics analysis services to various federal agencies, including the National Institutes of Health (NIH), Food and Drug...
- This is a firm fixed price purchase order awarded by the National Institute of Child Health and Human Development (NICHD), part of the National Institutes of Health (NIH), to Olink Proteomics AB, a foreign-owned for-profit company based in Sweden. The $69,388 contract is for Olink to provide laboratory services, specifically protein biomarker analysis using their proprietary multiplex platforms, to support NICHD's biomedical research across disease areas such as cancer, cardiovascular disease,...
- This is a $30,625.00 firm fixed-price purchase order contract awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute on Aging to Olink Proteomics Inc., a foreign-owned for-profit biotechnology company. The contract is for Olink's EXPLORE HT proteomics analysis service, which provides high-multiplex protein biomarker discovery capabilities. Olink Proteomics has a history of providing proteomics instruments, reagents, and analysis services to...
- This firm fixed-price purchase order was awarded by the National Institutes of Health (NIH) National Heart, Lung, and Blood Institute to Olink Proteomics AB, a foreign-owned for-profit organization, to provide Olink Biomarker Analysis Services. The $249,250.00 contract has a performance period through May 16, 2024 and does not have a set-aside designation. Olink Proteomics specializes in multiplex protein biomarker analysis platforms and has previously supported NIH, Food and Drug...
The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm fixed-price purchase order to Olink Proteomics AB, a foreign-owned for-profit organization based in Sweden, to provide 200 samples of Olink Explore 3072 protein analysis services for $140,000. The services will be performed in Watertown, Massachusetts. This award was made under a simplified acquisition without any set-aside, and the original solicitation sought a sole-source award to Olink to ensure data comparability across the agency's research efforts evaluating circulating biomarkers in cancer patients. Olink has provided similar proteomic analysis services to support various biomedical research initiatives at federal agencies like the NIH, FDA, and VA.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Proteomic Laboratory Testing Services | RFQ-NIAID-2086702 | Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases | Solicitation 1/1 | 9/7/21, 6:20 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $140.0k | 9/23/21 |